Viewing Study NCT01554332


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-25 @ 7:17 PM
Study NCT ID: NCT01554332
Status: UNKNOWN
Last Update Posted: 2020-06-12
First Post: 2012-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Motor Cortex Stimulation for Chronic Neuropathic Pain
Sponsor: Abbott Medical Devices
Organization:

Study Overview

Official Title: A Clinical Evaluation for the Management of Patients With Chronic Neuropathic Pain With Cortical Stimulation
Status: UNKNOWN
Status Verified Date: 2020-06
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the efficacy of cortical stimulation (CS) as an adjunctive treatment for chronic neuropathic pain.
Detailed Description: Prospective, controlled, double blind, randomized, crossover study with endpoint evaluations at the end of each 3-month treatment period.

An interim analysis will be conducted by a blinded committee when approximately half of the patients have finished the study.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: